MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
iRhythm Technologies Interest Expense 2011-2026 | IRTC
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense iRhythm Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.44 M | 1.25 M | -198 K | -314 K | 1.17 M | 1.52 M | 1.64 M | 3.12 M | 3.39 M | 3.25 M | 1.06 M | 774 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.44 M | -314 K | 1.84 M |
Quarterly Interest Expense iRhythm Technologies
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.16 M | - | 2.26 M | 875 K | - | 1.18 M | -305 K | -105 K | - | -108 K | 1.44 M | 950 K | - | 614 K | 482 K | 2.03 M | - | 279 K | 307 K | 335 K | - | 384 K | 381 K | 380 K | - | 409 K | 440 K | 409 K | - | 861 K | 861 K | 858 K | - | 862 K | 839 K | 822 K | - | 807 K | 803 K | 795 K | - | 222 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.26 M | -305 K | 695 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
-16.4 M | $ 60.58 | 0.33 % | $ 12.1 B |  USA |
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | USA |
 |
ICU Medical
ICUI
|
93.3 M | $ 120.37 | -2.13 % | $ 2.97 B | USA |
 |
Repro Med Systems
KRMD
|
9.91 K | $ 3.87 | -2.76 % | $ 179 M | USA |
 |
LeMaitre Vascular
LMAT
|
5.18 M | $ 97.52 | -1.99 % | $ 2.21 B | USA |
 |
Alcon
ALC
|
204 M | $ 63.93 | -0.14 % | $ 40.4 B |  Schweiz |
 |
Masimo Corporation
MASI
|
300 K | $ 178.4 | 0.03 % | $ 9.51 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-26 K | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
-2.3 M | $ 23.69 | -0.67 % | $ 3.98 B | USA |
 |
electroCore
ECOR
|
14.9 K | $ 6.29 | -2.18 % | $ 53.4 K | USA |
 |
Haemonetics Corporation
HAE
|
-9.75 M | $ 56.6 | -0.86 % | $ 2.85 B | USA |
 |
STAAR Surgical Company
STAA
|
2.25 M | $ 32.27 | 0.81 % | $ 1.6 B | USA |
 |
STERIS plc
STE
|
8.4 M | $ 214.08 | -0.88 % | $ 21.1 B | USA |
 |
Teleflex Incorporated
TFX
|
85.1 M | $ 128.92 | -1.04 % | $ 5.75 B | USA |
 |
Isoray
ISR
|
84 K | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
13.6 M | $ 141.43 | -0.52 % | $ 6.85 B | USA |
 |
InfuSystem Holdings
INFU
|
2 K | $ 8.57 | -0.46 % | $ 177 M | USA |
 |
Microbot Medical
MBOT
|
-5 K | $ 1.93 | 4.32 % | $ 88.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.33 | -1.64 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
-2.39 M | $ 62.4 | -0.26 % | $ 3.69 B | USA |
 |
Utah Medical Products
UTMD
|
-120 K | $ 63.24 | -0.72 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 301.39 | 0.4 % | $ 21.8 B | USA |
 |
Pulse Biosciences
PLSE
|
-52 K | $ 24.12 | -11.01 % | $ 1.63 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
24 M | $ 10.04 | -3.6 % | $ 2 B | USA |
 |
Retractable Technologies
RVP
|
227 K | $ 0.69 | - | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 59.95 | 2.22 % | $ 197 M | USA |
 |
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
1.82 M | $ 20.55 | -2.42 % | $ 981 M | USA |
 |
Stereotaxis
STXS
|
2 K | $ 1.87 | -3.86 % | $ 170 M | USA |
 |
Baxter International
BAX
|
290 M | $ 17.32 | -2.64 % | $ 8.89 B | USA |
 |
ResMed
RMD
|
3.2 M | $ 202.53 | -0.01 % | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
683 K | $ 28.37 | 0.79 % | $ 1.35 B | USA |
 |
Harvard Bioscience
HBIO
|
-2.66 M | $ 5.36 | -2.9 % | $ 238 M | USA |
 |
AngioDynamics
ANGO
|
4.94 M | $ 10.88 | -1.36 % | $ 444 M | USA |
 |
Becton, Dickinson and Company
BDX
|
613 M | $ 142.79 | -1.2 % | $ 41.1 B | USA |
 |
Nephros
NEPH
|
-78 K | $ 3.16 | -5.39 % | $ 33.5 M | USA |
 |
OraSure Technologies
OSUR
|
229 K | $ 3.08 | 4.24 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
2.82 M | $ 105.36 | 1.91 % | $ 5.92 M | USA |